KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.30 $3.29 Friday, 26th Apr 2024 ABUS stock ended at $2.73. This is 0.368% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.21% from a day low at $2.71 to a day high of $2.77.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
Apr 27, 2023 $2.56 $2.57 $2.47 $2.51 728 627
Apr 26, 2023 $2.55 $2.57 $2.50 $2.53 1 003 876
Apr 25, 2023 $2.62 $2.84 $2.51 $2.53 2 309 018
Apr 24, 2023 $3.00 $3.01 $2.89 $2.89 462 491
Apr 21, 2023 $2.94 $3.02 $2.93 $3.00 459 417
Apr 20, 2023 $2.99 $3.00 $2.94 $2.96 306 512
Apr 19, 2023 $2.94 $3.04 $2.90 $3.00 767 388
Apr 18, 2023 $2.91 $2.97 $2.88 $2.95 534 735
Apr 17, 2023 $2.86 $2.95 $2.84 $2.93 1 021 473
Apr 14, 2023 $2.91 $2.95 $2.85 $2.87 727 289
Apr 13, 2023 $2.82 $3.00 $2.81 $2.95 2 366 400
Apr 12, 2023 $2.94 $2.95 $2.80 $2.81 1 365 995
Apr 11, 2023 $2.88 $2.98 $2.88 $2.91 2 134 208
Apr 10, 2023 $2.91 $2.91 $2.85 $2.87 505 216
Apr 06, 2023 $2.91 $2.93 $2.83 $2.87 994 398
Apr 05, 2023 $3.00 $3.03 $2.87 $2.90 1 199 012
Apr 04, 2023 $3.06 $3.07 $2.97 $2.99 922 467
Apr 03, 2023 $3.03 $3.12 $3.01 $3.06 617 948
Mar 31, 2023 $3.04 $3.11 $3.00 $3.03 951 349
Mar 30, 2023 $3.10 $3.15 $3.01 $3.02 662 306
Mar 29, 2023 $3.02 $3.11 $3.00 $3.10 478 796
Mar 28, 2023 $3.06 $3.12 $3.00 $3.00 457 221
Mar 27, 2023 $3.01 $3.07 $2.98 $3.06 615 532
Mar 24, 2023 $2.95 $3.01 $2.88 $3.00 550 703
Mar 23, 2023 $2.95 $3.00 $2.92 $2.96 662 914
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT